Search hospitals
>
Pennsylvania
>
Lebanon
Sechler Family Cancer Center
Claim this profile
Lebanon, Pennsylvania 17042
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
72 reported clinical trials
9 medical researchers
Summary
Sechler Family Cancer Center is a medical facility located in Lebanon, Pennsylvania. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer, Cancer and other specialties. Sechler Family Cancer Center is involved with conducting 72 clinical trials across 100 conditions. There are 9 research doctors associated with this hospital, such as Amit B. Shah, Chanh T. Huynh, Dan Sotirescu, and Joseph Kannarkatt.
Area of expertise
Lung Cancer
Sechler Family Cancer Center has run 32 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Sechler Family Cancer Center has run 20 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Amit B. Shah
WellSpan Health-York Cancer Center
4 years of reported clinical research
Chanh T. Huynh
Adams Cancer Center
2 years of reported clinical research
Dan Sotirescu
Ephrata Cancer Center
6 years of reported clinical research
Joseph Kannarkatt
WellSpan Medical Oncology and Hematology
4 years of reported clinical research
Clinical Trials running at Sechler Family Cancer Center
Lung Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Cancer
Pancreatic Cancer
Prostate Adenocarcinoma
Depression
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sechler Family Cancer Center?
Sechler Family Cancer Center is a medical facility located in Lebanon, Pennsylvania. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer, Cancer and other specialties. Sechler Family Cancer Center is involved with conducting 72 clinical trials across 100 conditions. There are 9 research doctors associated with this hospital, such as Amit B. Shah, Chanh T. Huynh, Dan Sotirescu, and Joseph Kannarkatt.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.